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http://dx.doi.org/10.1016/j.bgm.201Abstract The study identified the most effective fraction and subfraction of hydro-methano-
lic extract (2:3) of the seed of Tamarindus indica Linn. (T. indica) having antidiabetic activity
in rats with diabetes induced by streptozotocin (STZ). The effective fraction and subfraction of
T. indica were subjected to an antidiabetic study in STZ-induced diabetic rats at two dose
levels, 100 mg/kg and 25 mg/kg body weight twice a day. Serum insulin, glycosylated hemoglo-
bin, carbohydrate metabolic enzymes, and transaminases were assessed and the histopathol-
ogy of the pancreas was examined after 8 weeks of treatment and compared to the vehicle
control. Treatment of n-hexane fraction at a dose of 100 mg/kg twice a day for 56 days in
STZ-induced diabetic rat resulted in a significant reduction in fasting blood glucose and glyco-
sylated hemoglobin levels along with a rise in serum insulin and glycogen contents in hepatic
and skeletal muscle in comparison to chloroform, ethyl acetate, or n-butanol fraction treated
groups as well as the untreated diabetic group. The most antidiabetic activity of n-hexaneof Bio-Medical Laboratory Science and Management, Vidyasagar University, Midnapore 721102, West
hoo.co.in (D. Ghosh).
an Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
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Antidiabetic activity of T. indica 165fraction had been highlighted by the activities of hexokinase, glucose-6-phosphate dehydroge-
nase, glucose-6-phosphatase, and lactate dehydrogenase in the liver, kidney, cardiac, and
skeletal muscle in respect with groups treated with other fractions. Two subfractions, A and
B, were obtained from the n-hexane fraction using petroleum ether, of which subfraction B
was more bioactive considering the above biosensors and was comparable with glibenclamide,
a standard antihyperglycemic drug. Chromatographic study by high performance thin layer
chromatography focused on two components of subfraction B, P1 and P2 where P1 is predom-
inant, conformed by high performance liquid chromatography. The dose of subfraction B was
25 mg/kg twice a day i.e., 1/4 dose of the n-hexane fraction. The n-hexane fraction and sub-
fraction B of T. indica are free from hepatic and renotoxicity according to the study of serum
transaminase.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Diabetes mellitus is a chronic and major endocrine disorder
caused by a deficiency in the production of insulin by the
pancreas or by the ineffectiveness of the insulin produced.1
Currently there are over 150 million diabetics worldwide and
this is likely to increase to 300 million or more by 2025. Sta-
tistical projection in India suggest that the number of di-
abetics will rise from 15 million in 1995 to 57 million in 2025
making India the countrywith the highest number of diabetics
in the world.2,3 Recent studies on geographical and ethnic
influences have shown that people of Indian origin are highly
prone to diabetes.4 A considerable amount of money is spent
onantidiabetic drugs, so the introductionof indigenous herbal
compounds in the management of diabetes mellitus will
greatly simplify the management and make it less expensive.
Compared with synthetic drugs, plant drugs are frequently
considered to be less toxic with fewer side effects.5
Tamarindus indica Linn. is a large and tall tree belonging
to the family Caesalpiniaceae that is found all over India.
These fruits are found mainly in summer; the seed coat is
brownish black in color and the kernel is white. Pharma-
cological studies of the plant have revealed that T. indica
possess anti-snake venom, antibacterial, antifungal, anti-
inflammatory, antimalarial, antioxidant, and hepator-
egenerative activities.6e9 In our previous work, aqueous
extract of seed of T. indica has also studied as an antidia-
betic agent.10 The antidiabetic efficacy of the extract was
compared with that of glibenclamide, a standard oral
antidiabetic drug.
The present study was designed to investigate the most
active fraction and subfraction of the hydromethanolic
extract of the seed of T. indica against hyperglycemia in
experimental diabetes along with the isolation of active
plant ingredients through high performance thin layer
chromatography (HPTLC) and high performance liquid
chromatography (HPLC) mediated purification.
Materials and methods
Collection of plant material
The plant material i.e. seeds of T. indica were collected
during the summer season (MayeJune) from the localmarket and agricultural fields of Midnapore and authen-
ticated by the Department of Botany, Vidyasagar Uni-
versity, West Bengal, India. The specimens were
preserved in the Department of Bio-Medical Laboratory
Science and Management as BMLSM-No.-03. The seeds
required for the study were first separated from the pulp.
The collected seeds were cleaned properly with tap
water and then with deionized water. The cleaned seeds
of the plant were dried completely at 40 C in the drying
oven. The dried seeds were pulverized separately in an
electrical grinder and were kept in self-sealing polythene
bags to avoid any contamination and for future experi-
mental studies.
Preparation of hydro-methanolic extracts
Pulverized seeds (5000 g) of T. indica were placed in a 20 L
percolator and maceration was carried out with 10 L hydro-
methanolic solution (H2O:MeOH 40:60) at 25
C to avoid any
degradation or deactivation of the active compound (s). The
slurrywas stirred intermittently for 1 hour and left overnight.
The extract was collected on the Day 2 after 24 hours of
extraction process and then freshly prepared 5 L hydro-
methanolic solution was added to the extraction chamber
and the slurry was stirred again with a glass rod. The same
procedure was repeated again on Day 3 with another 5 L of
solvent mixture and the extract was collected on Day 4. The
extract was filtered first by cotton filter and then by What-
man filters paper (No.1). The filtrate was evaporated under
reduced pressure by Rotavapour (BUCHI-R124; Bu¨chi, Flawil,
Switzerland) at 40C for the complete removal of methanol.
Finally plain aqueous filtrate (9.5 L free from methanol) was
lyophilized on VirTis bench top K lyophilizer (S.P Scientific,
Warminster, PA, USA). The lyophilized extract (920 g) was
collected and put into the amber colored glass containers,
which were stored in the refrigerator under vacuum for
subsequent fractionation and experimental studies. The
lyophilized extract was a mixture of dark brownish sticky
layer and light brownish solid powder (slightly hygroscopic in
nature).
Bioassay guided fractionation
In a 5 L separating flask, 600 g of lyophilized extract of T.
indica were dissolved with 2 L of hydromethanolic solution
Table 1 Comparative study of different fractions and subfraction of the seed of Tamarindus indica Linn. on body weight in
male albino rat: duration-dependent response.
Groups Duration of treatment and body weight (g)
Day 1 Day 28 Day 56
Control 145.58  4.63a 172.24  3.42a 198.62  2.14a
Untreated diabetic 147.31  3.82a 135.53  3.14b 124.82  3.75b
Diabetic þ n-hexane fraction 147.74  4.64a 168.65  2.67a 193.45  2.56a
Diabetic þ chloroform fraction 145.56  3.14a 161.35  3.18c 182.54  3.75c
Diabetic þ ethyl acetate fraction 147.54  3.65a 156.72  2.25d 168.24  3.21d
Diabetic þ n-butanol fraction 145.80  3.95a 154.63  2.87d 161.76  3.31d
Diabetic þ subfraction A fraction 147.47  4.46a 165.45  3.14a 190.24  4.61a
Diabetic þ subfraction B fraction 148.79  5.14a 170.62  4.13a 196.45  4.62a
Diabetic þ glibenclamide 146.36  3.27a 171.26  2.84a 194.42  4.71a
Data are expressed as mean  standard error of the mean, nZ 6, analysis of variance followed by multiple comparisons two-tail t test.
Values with different superscripts (aed) differ from each other significantly (p < 0.05).
166 D. De et al.and solvent fractionation was carried out using solvents
with increasing polarity (n-hexane, chloroform, ethyl ace-
tate, and n-butanol). Thin layer chromatography was car-
ried out to monitor the progress in fractionation. All
fractionates were collected separately and dried under
reduced pressure (20e200 mbar) using a rotavapour in-
strument at 40C. From 600 g of lyophilized extract of T.
indica, 2.5 g of n-hexane fraction, 19.4 g of chloroform
fraction, 61.8 g of ethyl acetate fraction, and 138.5 g of n-
butanol fraction were obtained. All the doses were
administered orally through gavage twice a day.
Subfraction of n-hexane fraction by petroleum
ether
A 1 g sample of n-hexane fraction was taken into an
eppendorf tube (T-2795, Sigma Aldrich (P-10), Taratalla
Road, 2nd floor, Kol-700 088) (2 mL) and 1 mL of petroleum
ether was added to it. The solution was then vortexed for 2
minutes for proper mixing. Finally the solution was centri-
fuged at 2800g for 5 minutes. After centrifugation, it was
observed that the solution had separated into two distinct
layers. The upper portion was liquid and oily in nature with
greenish color (subfraction A) whereas the lower portion
was a white colored solid compound (subfraction B). From
1 g of n-hexane fraction, 672 mg of subfraction A and
328 mg of subfraction B were obtained. Subfraction A and B
were administered orally through gavage.
Chemicals and reagents
Streptozotocin (STZ; Sigma-Aldrich Diagnostic Ltd., St
Louis, MO, USA) and glibenclamide (Medicare Pharmacy,
Allahabad, India) were purchased. Kits for the estimation of
glucose, serum glutamate oxaloacetate transaminase
(SGOT), and serum glutamate pyruvate transaminase
(SGPT) were from Span Diagnostics, Surat, India. All other
chemicals and reagents used for the study were of analyt-
ical grade obtained from E. Merck (Mumbai, India) or
HIMEDIA (Mumbai, India).Induction of diabetes mellitus
Diabetes was induced in male Wistar albino rats aged 3
months, body weight 145  5 g by single intramuscular in-
jection of STZ at the dose of 4 mg/0.1 mL of citrate buffer/
100 gbodyweight. After 48h ratswithmarkedhyperglycemia
(fasting blood glucose > 250 mg/dL and <400 mg/dL) were
selected and used for the study. Animals were housed at an
ambient temperature of 25  1 C with a 12-hour light/dark
cycle and fed with rat pellets diet (Hindustan Lever Limited,
Bangalore, India) andwaterad libitum in plastic cages, as per
the guidelines of the Vidyasagar University, Midnapore, West
Bengal, India Animal Ethics committee. The diabetic condi-
tion was tested for 7 successive days to monitor the stabili-
zation of diabetes.Experimental design
Screening for antihyperglycemic activity of the different
fractions and subfractions of n-hexane fraction of seed of T.
indica.
The rats were divided into nine groups and each group
consisted of six rats: Group 1, control rats; Group 2, dia-
betic untreated rats; Group 3, diabetic rats treated with
100 mg/kg n-hexane fraction twice a day; Group 4, diabetic
rats treated with 100 mg/kg chloroform fraction twice a
day; Group 5, diabetic rats treated with 100 mg/kg ethyl
acetate fraction twice a day; Group 6, diabetic rats treated
with 100 mg/kg n-butanol fraction twice a day; Group 7,
diabetic rats treated with 25 mg subfraction A/kg twice a
day; Group 8, diabetic rats treated with 25 mg subfraction
B/kg twice a day; and Group 9, diabetic rats treated with
20 mg/kg glibenclamide twice a day.
Every day, the first oral dose of the said fractions and
subfractions was given 1 hour prior to the supply of animal
feeds in the morning (at 08:00) and the second oral dose
was administered after 2 hours of the cleaning of feed box
at 17:00. Feeds were supplied again to the animals after 1
hour of the second oral administration of the said fractions
and subfractions. Animals of Group 1 and Group 2 were
Table 2 Corrective effect of 56 days of treatment with various fractions and subfraction of Tamarindus indica Linn. from hydromethanolic extract on blood glucose level in
STZ-induced diabetic rats.
Groups Fasting blood glucose level (mg/dL)
Day 1
(day of STZ
injection)
Day 7
(day of fraction
treatment)
Day 14 Day 21 Day 28 Day 35 Day 42 Day 49 Day 56
Control 74.03  2.42 a 73.45  2.35a 75.21  2.54 a 77.86  1.67 a 75.25  2.31 a 78.75  3.36a 81.45  2.82a 79.47  3.04a 77.37  3.24a
Untreated diabetic 75.58  3.12 a 337.32  2.84b 335.54  2.53b 338.63  2.75 b 341.52  2.14 b 339.36  1.95b 345.53  1.83b 342.52  2.02b 337.54  2.03b
Diabetic þ n-hexane
fraction
75.87  2.80a 348.62  3.34b 211.37  3.49c 158.57  2.15c 128.92  2.15c 115.74  2.67c 82.54  2.84a 80.54  3.24a 82.35  2.62a
Diabetic þ chloroform
fraction
76.56  1.98a 344.78  2.03b 264.43  2.51d 231.43  2.56d 188.32  1.76d 167.43  2.41d 140.64  3.18c 134.36  2.72c 139.53  2.27c
Diabetic þ ethyl acetate
fraction
74.63  2.41a 341.26  2.63b 268.54  4.24d 235.42  3.83d 205.82  4.52e 195.52  2.52e 121.53  2.63d 119.52  2.17d 117.53  2.62d
Diabetic þ n-butanol
fraction
76.57  2.64a 347.63  4.23b 296.45  3.54e 249.34  4.23e 203.34  3.65e 195.45  3.04f 212.35  2.52e 226.54  2.63e 228.64  3.05e
Diabetic þ subfraction A
fraction
75.72  2.53a 349.47  5.21b 302.65  4.65f 278.75  5.54f 247.54  4.43f 179.54  3.65f 148.76  3.54f 124.65  4.63f 122.54  3.66d
Diabetic þ subfraction B
fraction
76.48  3.54a 350.61  5.13b 212.73  4.56c 162.65  3.87c 129.56  3.56c 115.63  2.65c 81.65  2.85a 81.48  3.16a 79.42  2.87a
Diabetic þ glibenclamide 77.36  3.15a 346.31  2.42b 219.67  3.12c 167.61  2.82c 148.35  2.42c 119.54  2.05c 92.52  2.15g 94.43  3.02g 93.73  2.53f
Data are expressed as mean  standard error of the mean, nZ 6, analysis of variance followed by multiple comparisons two-tail t test. Values with different superscripts (aeg) differ from
each other significantly (p < 0.05).
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Figure 1 Protective effect of n-hexane, chloroform, ethyl
acetate, n-butanol, subfraction A, and subfraction B on serum
insulin level in streptozotocin-induced diabetic rat. Each bar
represents mean  standard error of the mean, nZ 6 for each
group. Analysis of variance followed by multiple comparison
two-tail t test. Values of bar diagrams with different super-
scripts (aee) differ from each other significantly at the level of
p < 0.05.
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Figure 3 Comparative analysis of n-hexane, chloroform,
ethyl acetate, n-butanol, subfraction A, and subfraction B on
glycogen level in streptozotocin-induced diabetic rat. Each bar
represents mean  standard error of the mean, nZ 6 for each
group. Analysis of variance followed by multiple comparison
two-tail t test. Values of bar diagrams with different super-
scripts (aee) differ from each other significantly at the level of
p < 0.05.
168 D. De et al.subjected to gavage of 0.5 mL water/100 g body weight/
rat/day for 49 days at the time of fractions, subfractions,
and glibenclamide administration to the animals of Groups
3e9, to keep all the animals under the same experimental
condition and stress imposition, if any, due to the admin-
istration of fractions and animal handling. Starting from
Day 1 of fractions and subfractions administration to the
diabetic rats, fasting blood glucose levels (12 hours after
feed delivery) were measured in all groups on every week.
On Day 56 of the experiment peripheral blood was collected
by retro orbital puncture under light anesthesia at the 12-0
1
2
3
4
5
6
7
8
9
Glycosylated hemoglobin
%
 
o
f
 
g
l
y
c
o
s
y
l
a
t
e
d
 
h
e
m
o
g
l
o
b
i
n
Control
Untreated diabetic
Diabetic + n-hexane fraction
Diabetic + chloroform fraction
Diabetic + ethyl acetate fraction
Diabetic + n-butanol fraction
Diabetic + subfraction A
Diabetic + subfraction B
Diabetic + glibenclamide
a
b
a
c c
d
c
a
c
Figure 2 Effect of n-hexane, chloroform, ethyl acetate, n-
butanol, subfraction A, and subfraction B on glycosylated he-
moglobin level in streptozotocin-induced diabetic rat. Each bar
represents mean  standard error of the mean, nZ 6 for each
group. Analysis of variance followed by multiple comparison
two-tail t test. Values of bar diagrams with different super-
scripts (aed) differ from each other significantly at the level of
p < 0.05.hour fasting state and the fasting glucose level was moni-
tored. All the animals were sacrificed at the fasting state by
light ether anesthesia followed by decapitation after
recording the final body weight. Blood was collected from
the dorsal aorta by a syringe and the serum was separated
by centrifugation at 2800 g for 5 minutes for the estimation
of serum insulin and serum toxicity study. The liver, kidney,
skeletal muscle, and cardiac muscle were dissected out and
stored at 20C for the quantification of hepatic and
skeletal muscle glycogen, assessment of the activities
of the carbohydrate metabolic enzymesdhexokinase,
glucose-6-phosphate dehydrogenase (G6PDH), glucose-6-
phosphatase (G6P), and lactate dehydrogenase (LDH) in
the liver, kidney, skeletal muscle, and cardiac muscle.
Blood was used for the quantification of glycated
hemoglobin.
Measurement of fasting blood glucose level
At the time of grouping of the animals, fasting blood glucose
level was measured. After every 6 days (on every 7th day) of
treatment, fasting blood glucose was further recorded from
all the animals of all groups. The blood samples were with-
drawn from the animals by retro-orbital puncture under light
anesthesia. The plasma glucose estimation was done by the
glucose oxidase/peroxidase11 method using a standard kit
obtained from Span Diagnostics.
Biochemical measurement
Serum insulin levelsweremeasuredby following themethods
of Bu¨rgi et al (1988)12 using rat insulin enzyme linked
immunosorbent assay kit (Millipore Corporation, Billerica,
MA, USA). Glycosylated hemoglobin level was measured ac-
cording to Chandalia et al (1980).13 The hepatic glycogen
level was measured according to the standard methods of
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Figure 4 Protective effect of n-hexane, chloroform, ethyl acetate, n-butanol, subfraction A, and subfraction B on hexokinase in
liver, kidney, skeletal muscle, and cardiac muscle in streptozotocin-induced diabetic rat. Each bar represents mean  standard
error of the mean, n Z 6 for each group. Analysis of variance followed by multiple comparison two-tail t test. Values of bar di-
agrams with different superscripts (aee) differ from each other significantly, p < 0.05.
Antidiabetic activity of T. indica 169Kemp and Van Hejnigen.14 The activities of the carbohydrate
metabolic were assayed by previously described meth-
ods.15e18 SGOT and SGPT activities were measured by the
methods of Henry et al19 using a semiautoanalyzer kit ob-
tained from Merck Limited.
Histological parameters
The midpart of the pancreas was collected from all the
groups to avoid error due to the variation in size of islets in
different parts of the pancreas. The pancreas was fixed in a
neutral buffered formalin solution (10%) and dehydrated in
a graded series (50%, 70%, 80%, 90%, 95%, and 100%) of
ethanol. The tissue was embedded in Paraplast, sectioned
into approximately 4 mm thicknesses and stained with he-
matoxylin and eosin. The tissues were observed using a
light microscope. Diameters of the pancreatic islets were
measured by computerized microphotography using soft-
ware (For microphotography: AverPac Version 2.5, Aver-
Media Technologies Inc. Fremont, CA, USA. ForGlucose-6-ph
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Figure 5 Correction of glucose-6-phosphatase activities in liver, k
of n-hexane, chloroform, ethyl acetate, n-butanol, subfraction A an
represents mean  standard error of the mean, nZ 6 for each group
t test. Values of bar diagrams with different superscripts (aed) difmeasurement: DeWinter Caliper Pro-Software, Version 3.0,
DeWinter Optical Inc. West Patel Nagar, Delhi, India).20
Statistical analysis
Data were evaluated statistically using one-way analysis of
variance (ANOVA) followed by multiple comparison two-tail
t test by using Origin Lab (Version 6.0) software (Origin Lab
Corporation. North Antton, One Round House Plaza, MA
01060, USA). A p value < 0.05 was considered to indicate
statistical significance. Data are presented as
mean  standard error of the mean.
Results
Body weight
Table 1 shows that the final body weight of the untreated
control group increasedsignificantlycomparedto thebeginningosphatase
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Figure 6 Comparative analysis of the correction in glucose-6-phosphate dehydrogenase in liver, kidney, skeletal muscle, and
cardiac muscle in streptozotocin-induced diabetic rat by n-hexane, chloroform, ethyl acetate, n-butanol, subfraction A, and
subfraction B treatment. Each bar represents mean  standard error of the mean, n Z 6 for each group. Analysis of variance
followed by multiple comparison two-tail t test. Values of bar diagrams with different superscripts (aed) differ from each other
significantly, p < 0.05.
170 D. De et al.of the experiment, whereas a significant decrease in body
weight was observed in the diabetic group in respect to the
control. Administration of n-hexane, chloroform, ethyl ace-
tate, and n-butanol fractions and subfractions A and B of T.
indica resulted a significant increase in body weight compared
to the diabetic group. The recovery in body weight was signif-
icant with the n-hexane fraction and subfraction B in compar-
ison toother fractions and subfractionA treatedgroups and this
change was comparable to the glibenclamide treated group.
Fasting blood glucose level
Table 2 shows that there was a significant decrease in
fasting blood glucose levels in diabetic treated rats after
the administration of n-hexane, chloroform, ethyl acetate,
and n-butanol fractions at the dose of 100 mg/kg twice a
day. Administration of n-hexane fraction of T. indica toLactate dehyd
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t test. Values of bar diagrams with different superscripts (aee) difdiabetic animals resulting in a more significant corrective
effect than other fractions on the blood glucose level. After
the treatment of subfraction A or B from the n-hexane
fraction there was a significant reduction of blood glucose
level in the diabetic group but subfraction B was more
effective in this concern. The n-hexane fraction and sub-
fraction B also had more potent action than the glibencla-
mide in this concern.
Serum insulin
Serum levels of insulin were decreased significantly in un-
treated diabetic test animals as compared with nondiabetic
control animals. Administration of n-hexane fraction of T.
indica to diabetic animals resulted in a significant corrective
effect than other fractions on the levels of insulin. Admin-
istration of subfraction A, subfraction B, or glibenclamide torogenase
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bar represents mean  standard error of the mean, n Z 6 for
each group. Analysis of variance followed by multiple com-
parison two-tail t test. Values of bar diagrams with different
superscripts (aec) differ from each other significantly at the
level of p < 0.05.
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and again, subfraction B was more effective (Fig. 1).
Glycosylated hemoglobin
Glycosylated hemoglobin level is one of the important in-
dicators of a diabetic condition, and the level of the
parameter was increased significantly in the diabetic group
in comparison with the control group. After administration
of n-hexane, chloroform, ethyl acetate, and n-butanol ex-
tracts of T. indica in a STZ-induced diabetic rat, the level of
this parameter was recovered towards the control level.
After the treatment of n-hexane subfractions there was a
significant reduction of glycosylated hemoglobin level in
the diabetic group. Subfraction B was more effective in this
concern than subfraction A or glibenclamide (Fig. 2).
Hepatic and skeletal muscle glycogen
The levels of hepatic and skeletal muscle glycogen were
decreased in the untreated diabetic group in comparison
with the nondiabetic control group. The administration of
n-hexane, chloroform, ethyl acetate, or n-butanol fraction
to diabetic animals resulted in a significant recovery in this
parameter, but the administration of n-hexane produced
the most significant recovery in the test animals in com-
parison with those treated with any other individual frac-
tion. The administration of subfraction A or B from n-
hexane fraction or glibenclamide to the diabetic animal
resulted in a significant recovery in the level of liver
glycogen, but the administration of subfraction B was more
effective in comparison with those animals treated with
subfraction A or glibenclamide (Fig. 3).
Hexokinase, G6P, G6PDH, and LDH in hepatic,
kidney, skeletal muscle, and cardiac muscle
Figs. 4e7 show that the activities of hexokinase and
G6PDH in hepatic, kidney, skeletal muscle, and cardiacmuscle were decreased, but the activities of G6P and
lactate dehydrogenase in these tissues were increased in
the untreated diabetic group in comparison with the
nondiabetic control group. The administration of the n-
hexane, chloroform, ethyl acetate, and n-butanol ex-
tracts to diabetic animals resulted in a significant recov-
ery in these metabolic reactions but the administration of
n-hexane produced a more significant recovery to normal
in comparison with those animals treated with any of the
individual fractions. The administration of n-hexane sub-
fractions to a diabetic animal resulted in a significant
recovery in the metabolic reactions. Subfraction B resul-
ted in a more significant recovery in the levels of these
parameters towards normal in the test animals in com-
parison with those animals treated with subfraction A or
glibenclamide.
SGOT and SGPT
Activities of SGOT and SGPT were increased in the diabetic
group compared to the control group. After administration of
the n-hexane fraction and subfraction B, there was a sig-
nificant recovery in the levels of these parameters. Sub-
fraction B was more effective than glibenclamide (Fig. 8).
Histological study
The diameter of pancreatic islets as well as the count of
islet cells was significantly decreased in the STZ-induced
diabetic group in respect to the control group. The values
of these parameters were significantly recovered after the
treatment of n-hexane, chloroform, ethyl acetate, n-
butanol, subfraction A, or subfraction B in diabetic rats
but the most promising result was obtained after the
treatment with n-hexane fraction and subfraction B
(Fig. 9).
HPTLC fingerprinting of the most effective fraction
and subfraction
To identify the number of compounds present in the active n-
hexane fraction of T. indica, HPTLC fingerprinting was per-
formed using chloroform:methanol:ethyl acetate 90:5:5 v/v
as a suitable solvent systemdeduced fromapilot study. From
this study it was observed that the fraction was a mixture of
six different compounds. HPTLC finger printing was also
carried out to examine the number of compounds present in
subfraction B. After the HPTLC study it was observed that
subfraction B contained two different compounds in which
one was very prominent (P1) on chromatographic plate and
the other was very faint (P2; Fig. 10).
HPLC analysis of the most effective subfraction
Analytical RP-HPLC (Waters Corporation, 34 Maple Street,
Milford,MA 01757, USA)was performed tofind out the number
of compounds present in the solid subfraction of petroleum
ether (subfraction B) of the n-hexane fraction of seed of T.
indica (Fig. 11). This studywas also carried out toestablish the
purity percentage of the isolated compound as well the lmax
values. HPLC analysis was performed on the Water Alliance
Figure 9 (A) Representative sample of pancreatic tissue of vehicle control rat focusing on the normal islet diameter. (B)
Diminution in the diameter of islet in the representative pancreatic tissue sample of streptozotocin (STZ)-induced diabetic rat. (C)
Representative pancreatic tissue sample showing recovery in islet cell diameter after n-hexane fraction of hydro-methanolic
extract treatment in a streptozotocin-induced diabetic rat. (D) Pancreatic tissue sample showing recovery in islet cell diameter
after treatment of chloroform fraction of hydro-methanol extract of seed of Tamarindus indica Linn. in a STZ-induced diabetic rat.
(E) Pancreatic tissue sample showing recovery in islet cell diameter after treatment of ethyl acetate fraction of hydromethanol
extract in a STZ-induced diabetic rat. (F) Pancreatic tissue sample showing recovery in islet cell diameter after treatment of n-
butanol fraction of hydro-methanol extract in a STZ-induced diabetic rat. (G) Pancreatic tissue sample showing recovery in islet
cell diameter after treatment of subfraction A in a STZ-induced diabetic rat. (H) Pancreatic tissue sample showing recovery in islet
cell diameter after treatment of subfraction B in a STZ-induced diabetic rat. (I) Representative pancreatic tissue sample showing
recovery in islet cell diameter after glibenclamide treatment.
172 D. De et al.HPLC system equipped with 2695 separation module 2996
Photodiode Array Detector, performance plus four-channel
inline Degasser auto injector, quaternary pump, and column
oven. The HPLC analysis was carried out on the Thermo
Hypersil BDS C18 (4.6 mm  250 mm, 5 mm) column using a
premixed solvent system as amobile phasewith a flow rate of
1 mL/minute and Isocratic Illusion Technique. The column
temperature was maintained at 30C and detection was per-
formed at 254 nm. For the HPLC study, the white solid layer
was separately dissolved with a mobile phase (ethyl aceta-
te:hexane:isopropyl alcohol 60:30:10) The solution was soni-
cated for 15minutes and thenfiltered throughMillipore Millex
Syringe filter unit (0.45 mm). The sample solution of 10 mLinjected through the autoinjector fitted with a 200-mL syringe
and 100-mL sample loop. The separated compounds scanned
across the entire UV range on three-dimensional spectral
mode to record the photodiode array detector spectra. HPLC
chromatograms of isolated compounds were recorded at
254 nm. Data from the Water Alliance HPLC system were ac-
quired and processed using Water Millennium32 software.Discussion
The present study was conducted to identify the possible
active principle(s) having antihyperglycemic activity
Figure 10 High performance thin layer chromatogram of
subfraction B, Scan at 254 nm of different concentration (3
dimensional), five tracks of different volume (according to
behind to in front 5 mL, 10 mL, 15 mL, 20 mL, 25 ml ) of the same
sample are shown here.
Antidiabetic activity of T. indica 173present in the n-hexane fraction followed by subfractions
of T. indica seed. The n-hexane fraction showed a more
significant reduction than other fractions in blood glucose
levels in STZ-induced diabetic rats. The n-hexane fraction
produced a maximum antidiabetic activity, as has been
established from the comparative study with glibenclamide
in the diabetic rats.
The levels of blood glucose, serum insulin, and glycosy-
lated hemoglobin were noted in normal and experimental
groups of rats. There was a significant elevation in blood
glucose and glycosylated hemoglobin, whereas the level of
serum insulin decreased in the diabetic group when
compared with the control group.21 Administration of n-
hexane fraction and subfraction B of T. indica resulted in aFigure 11 Representative high performance liquid chro-
matogram of petroleum ether subfraction B from the n-hexane
fraction.significant recovery to near normal values as that of the
standard drug glibenclamide treatment.
Restoration in the glycogen level with fraction treat-
ment may be explained by the recovery of insulin, as insulin
controls the activity of glycogen synthetase.22 Such recov-
ery of insulin has been indicated by a serum insulin level
assessment as well as from histological evaluation of islets.
For the assessment of the antidiabetic potency of the
plant extract, we measured the activity of hepatic G6P, an
important enzyme for glycogenolysis.23 Similarly G6PDH
and hexokinase are two enzymes that are under the posi-
tive control of insulin.24 In the diabetic state, the activities
of these three enzymes are altered as reported previ-
ously.25,26 The n-hexane fraction and subfraction B are able
to recover the activities of these enzymatic biosensors
significantly and are comparable to glibenclamide, which
may be due to the recovery of insulin.
LDH is a bifunctional enzyme involved in the glycolytic
pathway. The LDH system reflects the nicotinamide
adenine dinucleotide (NADþ)/NADH ratio indicated by the
lactate/pyruvate ratio of hepatocyte cytosol. In different
fractions of T. indica or glibenclamide treated groups of
rats, the reduction in the LDH activity is probably due to
the regulation of NADþ/ NADH ratio by the oxidation of
NADH.
There was no toxicity of this extract as proved by SGOT
and SGPT activities, as these enzymes are important sen-
sors for toxicity assessment.27 In respect to LD50 values and
maximum nonfatal doses studies revealed the nontoxic
nature of the n-hexane fraction and subfraction B of this
plant. There was no lethality or any toxic reactions found at
any of the doses selected up to the end of the study period.
According to a toxicity classification,28 the n-hexane frac-
tion of T. indica was nontoxic.
To find the number of active biomolecules for the
management of STZ-induced a diabetic subfraction study
using petroleum ether was conducted. Subfraction B was
more effective than subfraction A at a dose that was 1/4 of
the dose of n-hexane fraction. From HPLC analysis it has
been found that there are two components named as P1 and
P2, where P1 was more prevalent in the petroleum ether
subfraction B. Therefore, it may be concluded that the
single phytomolecule P1 may be the causative molecule for
the management of diabetes mellitus from the seed of T.
indica. Further work is necessary for characterization of
the biologically active ingredients present in the seed of T.
indica.
Acknowledgments
The authors are thankful to the Indian Council of Medical
Research (ICMR), New Delhi, India, for its financial support.
References
1. Veeramani C, Pushpavalli G, Pugalendi K. Antihyperglycaemic
effect of Cardiospermum halicacabum Linn. leaf extract on
STZ-induced diabetic rats. J Appl Biomed. 2008;6:19e26.
2. King H, Aubert RE, Herman WH. Global burden of diabetes
1995-2025: prevalence, numerical estimates and projections.
Diabet Care. 1998;21:1414e1431.
174 D. De et al.3. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of dia-
betes burden through 2050: Impact of changing demography and
disease prevalence in the US. Diabet Care. 2001;24:1936e1940.
4. Kumar A, Ilavarasan R, Jayachandran T, et al. Anti-diabetic
activity of Syzygium cumini and its isolated compound against
streptozotocin-induced diabetic rats. J Med Plants Res. 2001;2:
246e249.
5. Ukwe CV, Ubaka CM. Hypoglycemic activity of leaves of Acan-
thus montanus T. Anderson (Acanthaceae) in rats. Int J Dia-
betes Dev Ctries. 2011;31:32e36.
6. Ushanandini S, Nagaraju S, Harish Kumar K, et al. The anti-
snake venom properties of Tamarindus indica (Leguminosae)
seed extract. Phytother Res. 2006;20:851e858.
7. Jha N, Jha A, Pandey I. Tamarindus indica: Tamarind: Imli.
Phytopharm. 2005;6:1e6.
8. Sudjaroen Y, Haubner R, Wu¨rtele G, et al. Isolation and
structure elucidation of phenolic antioxidants from Tamarind
(Tamarindus indica L.) seeds and pericarp. Food Chem Toxical.
2005;43:1673e1682.
9. Pimple BP, Kadam PV, Badgujar NS, et al. Protective effect of
Tamarindus indica Linn against paracetamol-induced hepato-
toxicity in Rats. Ind J Pharmaceutic Sc. 2007;69:827e831.
10. Maiti R, Das UK, Ghosh D. Attenuation of hyperglycemia and
hyperlipidemia in streptozotocin induced diabetic rats by
aqueous extract of seed of Tamarindus indica. Biol Pharm Bull.
2005;28:1172e1176.
11. Ragavan B, Krishnakumari S. Antidiabetic effect of T. arjuna
bark extract in alloxan induced diabetic rats. Ind J Clin Bio-
chem. 2006;21:123e128.
12. Bu¨rgi W, Briner M, Fraken N, et al. One step sandwich enzyme
immunoassay for insulin using monoclonal antibodies. Clin
Biochem. 1988;21:311e314.
13. Chandalia HB, Sadikot S, Bhargava DK, et al. Estimation of
glycosylated hemoglobin by a simple chemical method. J Assoc
Physicians India. 1980;29:285e286.
14. Kemp A, Van Hejnigen AJMK. A colorimetric micro-method for
the determination of glycogen in tissues. Biochem J. 1954;56:
646e648.
15. Langdon RG. Glucose-6-phosphate dehydrogenase from eryth-
rocytes. In: Wood WA, ed. Methods in Enzymology. Vol. IX. New
York: Academic Press; 1966:126e131.16. Chou AC, Wilson JE. Carbohydrate metabolism. In: Wood Wa,
ed. Methods in Enzymology. Vol. XLII. New York: Academic
Press; 1975:20e21.
17. Swanson MA. Glucose-6-phosphatase from liver. In:
Colowick SP, Kaplan NO, eds. Methods in Enzymology. Vol. II.
New York: Academic Press; 1955:541e543.
18. Anon Z. Determination of LDH by UV-kinetic method. Z. Klin.
Chem. U. Klin Biochem. 1970;8:658.
19. Henry RJ, Chiamori M, Gonub OJ, et al. Revised spectropho-
tometric methods for the determination of glutamate oxal-
acetic transaminase, glutamic pyruvate transaminase and
lactic acid dehydrogenase. Am J Clin Pathol. 1960;34:
381e398.
20. Noor A, Gunasekaran S, Soosai Manickam A, et al. Antidiabetic
activity of Aloe vera and histology of organs in streptozotocin
induced diabetic rats. Current Sci. 2007;94:1070e1076.
21. Kasetti RB, Rajasekhar MD, Kondeti VK, et al. Anti-
hyperglycemic and antihyperlipidemic activities of methanol:
water (4:1) fraction isolated from aqueous extract of Syzygium
alternifolium ses in streptozotocin induced diabetic rats. Food
Chem Toxicol. 2010;48:1078e1084.
22. Sridevi M, Senthil S, Pugalendi KV. Antihyperglycemic effect of
Solanum surattense leaf-extract in streptozotocin induced
diabetic rat. J Pharmacol Toxicol. 2007;6:621e629.
23. Aiston S, Andersen B, Agius L. Glucose 6- phosphate regulates
hepatic glycogenolysis through inactivation of phosphorylase.
Diabetologia. 2003;52:1333e1339.
24. Kruszynska YT, Mulford MI, Baloga J, et al. Regulation of
skeletal muscle hexokinase II by insulin in nondiabetic and
NIDDM subjects. Diabetologia. 1998;47:1107e1113.
25. Rajasekaran S, Sivagnanam K, Ravi K, et al. Hypoglycemic ef-
fect of Aloe vera on streptozotocin induced diabetes in
experimental rats. J Med Food. 2004;7:61e66.
26. De D, Chatterjee K, Ali KM, et al. Antidiabetic and anti-
oxidative effects of hydro-methanolic extract of sepals of
Salmalia malabarica in streptozotocin induced diabetic rats. J
Appl Biomed. 2010;8:23e33.
27. Ghosh S, Suryawanshi SA. Effect of Vinca rosea extracts in
treatment of alloxan diabetes in male albino rats. Ind J
Experiment Biol. 2001;39:748e759.
28. Loomis TA. Essential of Toxicology. Phil Le. 1968;6:67e68.
